Michael G. Spigarelli

2.2k total citations
78 papers, 1.5k citations indexed

About

Michael G. Spigarelli is a scholar working on Epidemiology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael G. Spigarelli has authored 78 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 24 papers in Pharmacology and 20 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael G. Spigarelli's work include Antibiotics Pharmacokinetics and Efficacy (21 papers), Pneumonia and Respiratory Infections (15 papers) and Cystic Fibrosis Research Advances (12 papers). Michael G. Spigarelli is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (21 papers), Pneumonia and Respiratory Infections (15 papers) and Cystic Fibrosis Research Advances (12 papers). Michael G. Spigarelli collaborates with scholars based in United States, Canada and New Zealand. Michael G. Spigarelli's co-authors include Catherine M.T. Sherwin, Chris Stockmann, Krow Ampofo, Tony K. L. Kiang, Mary H. H. Ensom, David C. Young, Jessica K. Roberts, Jeffery T. Zobell, C. Dustin Waters and Jonathan E. Constance and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Michael G. Spigarelli

78 papers receiving 1.4k citations

Peers

Countries citing papers authored by Michael G. Spigarelli

Since Specialization

Citations

This map shows the geographic impact of Michael G. Spigarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Spigarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Spigarelli more than expected).

Fields of papers citing papers by Michael G. Spigarelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Spigarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Spigarelli. The network helps show where Michael G. Spigarelli may publish in the future.

Co-authorship network of co-authors of Michael G. Spigarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Spigarelli. A scholar is included among the top collaborators of Michael G. Spigarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Spigarelli. Michael G. Spigarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov 2024 ·Drug Design Development and Therapy ·(unknown), Michael G. Spigarelli	8
2	A Retrospective Study of Kidney Injury vs Vancomycin Use by Age 2015 ·Clinical Pharmacology in Drug Development ·Alfred H. Balch, Jonathan E. Constance, Michael G. Spigarelli, Catherine M.T. Sherwin	1
3	Quantitative Assay Validation for Oxandrolone in Human Plasma Using LC–MS-MS 2015 ·Journal of Analytical Toxicology ·(unknown), Chris Stockmann, Sarah Campbell, Richard V. Williams, Phillip T. Burch, Linda M. Lambert, Catherine M.T. Sherwin, Christopher A. Reilly, Michael G. Spigarelli	2
4	Regional Differences in Thiopurine Methyltransferase Activity 2014 ·Clinical Pharmacology in Drug Development ·(unknown), Sarah Campbell, Chris Stockmann, Kamisha L. Johnson‐Davis, Gwendolyn A. McMillin, Catherine M.T. Sherwin, Michael G. Spigarelli	3
5	Dance (Darbe Administration in Newborns Undergoing Cooling for Encephalopathy): Safety and Pharmacokinetic Trial 2014 ·CORE Scholar (Wright State University) ·Jessica K. Roberts, Joanna Beachy, Bradley A. Yoder, Robert M. Ward, Catherine M.T. Sherwin, Michael G. Spigarelli, Robert DiGeronimo, Robin K. Ohls, William F. Walsh, Dennis E. Mayock, Sandra E. Juul, Robert D. Christensen, Mariana Baserga	3
6	Evaluation of Disparities in Achieving TherapeuticRecommendations Among Pediatric Patients Receiving Gentamicin 2014 ·Clinical Pharmacology in Drug Development ·Jonathan E. Constance, Alfred H. Balch, Catherine M.T. Sherwin, E. Kent Korgenski, Michael G. Spigarelli	3
7	Relationship Between Zolpidem Concentrations and Sleep Parameters in Pediatric Burn Patients 2014 ·Journal of Burn Care & Research ·Chris Stockmann, Michele M. Gottschlich, Daniel P. Healy, Jane Khoury, Theresa Mayes, Catherine M.T. Sherwin, Michael G. Spigarelli, Richard J. Kagan	6
8	Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis 2014 ·Journal of Pharmacokinetics and Pharmacodynamics ·Catherine M.T. Sherwin, Jeffery T. Zobell, Chris Stockmann, (unknown), (unknown), David C. Young, Jared Olson, Krow Ampofo, Michael G. Spigarelli	20
9	Use of Methylxanthine Therapies for the Treatment and Prevention of Apnea of Prematurity 2014 ·Pediatric Drugs ·(unknown), Yu Tian, Chris Stockmann, Michael G. Spigarelli, Catherine M.T. Sherwin	48
10	Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection 2014 ·Expert Opinion on Drug Metabolism & Toxicology ·Chris Stockmann, Jessica K. Roberts, Elizabeth D Knackstedt, Michael G. Spigarelli, Catherine M.T. Sherwin	39
11	Pharmacology and Pharmacogenomics of Neurological Medications Used in Pregnancy 2013 ·Clinical Obstetrics & Gynecology ·Sarah Campbell, Michael G. Spigarelli	2
12	Amikacin population pharmacokinetics among paediatric burn patients 2013 ·Burns ·Catherine M.T. Sherwin, (unknown), Chris Stockmann, Daniel P. Healy, Michael G. Spigarelli, Alice N. Neely, Richard J. Kagan	22
13	Considerations in the Pharmacologic Treatment and Prevention of Neonatal Sepsis 2013 ·Pediatric Drugs ·Chris Stockmann, Michael G. Spigarelli, Sarah Campbell, Jonathan E. Constance, Joshua Courter, Emily A. Thorell, Jared K. Olson, Catherine M.T. Sherwin	26
14	Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov 2013 ·International Journal of Antimicrobial Agents ·Chris Stockmann, Catherine M.T. Sherwin, Krow Ampofo, Adam L. Hersh, Andrew T. Pavia, Carrie L. Byington, Robert M. Ward, Michael G. Spigarelli	5
15	Age-Specific Patterns of Influenza Activity in Utah: Do Older School Age Children Drive the Epidemic? 2013 ·Journal of the Pediatric Infectious Diseases Society ·Chris Stockmann, Andrew T. Pavia, Adam L. Hersh, Michael G. Spigarelli, (unknown), Kent Korgenski, Carrie L. Byington, Krow Ampofo	3
16	Fundamentals of Population Pharmacokinetic Modelling 2012 ·Clinical Pharmacokinetics ·Catherine M.T. Sherwin, Tony K. L. Kiang, Michael G. Spigarelli, Mary H. H. Ensom	88
17	Urine gonococcal/Chlamydia testing in adolescents 2006 ·Current Opinion in Obstetrics & Gynecology ·Michael G. Spigarelli	5
18	Computed tomography scanning of hepatic tumors with polyiodinated triglycerides 1996 ·Academic Radiology ·Jamey P. Weichert, (unknown), Marc A. Longino, (unknown), Michael G. Spigarelli, Isaac R. Francis, Raymond E. Counsell	8
19	Computed tomography scanning of morris hepatomas with liver-specific polyiodinated triglycerides 1996 ·Academic Radiology ·Jamey P. Weichert, Marc A. Longino, Michael G. Spigarelli, Fred T. Lee, Susan W. Schwendner, Raymond E. Counsell	7
20	Polyiodinated Triglyceride Analogs as Potential Computed Tomography Imaging Agents for the Liver 1995 ·Journal of Medicinal Chemistry ·Jamey P. Weichert, Marc A. Longino, (unknown), Michael G. Spigarelli, (unknown), Susan W. Schwendner, Raymond E. Counsell	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact